Trial Profile
A Prospective Randomized Clinical Trial Using Dehydrated Human Amnion/Chorion Membrane (dHACM) in Total Knee Replacement Patients to Reduce Post-operative Scarring.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs DHACM (Primary)
- Indications Postoperative complications
- Focus Therapeutic Use
- Sponsors MiMedx
- 24 Aug 2015 New trial record